Showing results (41-50 of 197) with videos related to
Sort By:
Pageof 20
Nucleic Acids Research|June 1, 2019
Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell diseaseSo Hyun Park, Ciaran M Lee, Daniel P Dever, et al.RNA Biology|January 18, 2013
Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitorsAnne Kruse Hollensen, Rasmus O Bak, Didde Haslund, et al.Cytokine|August 25, 2012
Regulation of pro-inflammatory cytokines TNFα and IL24 by microRNA-203 in primary keratinocytesMaria Nascimento Primo, Rasmus O Bak, Beatrice Schibler, et al.Genome Research|January 13, 2025
Characterization of the role of spatial proximity of DNA double-strand breaks in the formation of CRISPR-Cas9-induced large structural variationsMikkel Dahl-Jessen, Thorkild Terkelsen, Rasmus O Bak, et al.Nature Medicine|March 19, 2021
Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cellsM Kyle Cromer, Joab Camarena, Renata M Martin, et al.The EMBO Journal|July 1, 2006
Human SMC5/6 complex promotes sister chromatid homologous recombination by recruiting the SMC1/3 cohesin complex to double-strand breaksPatrick Ryan Potts, Matthew H Porteus, Hongtao YuNature Communications|January 3, 2024
Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cellsRon Baik, M Kyle Cromer, Steve E Glenn, et al.Nature Biotechnology|June 30, 2015
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cellsAyal Hendel, Rasmus O Bak, Joseph T Clark, et al.Plos Genetics|October 3, 2006
A look to future directions in gene therapy research for monogenic diseasesMatthew H Porteus, Jon P Connelly, Shondra M PruettBlood|April 8, 2016
Ethical and regulatory aspects of genome editingDonald B Kohn, Matthew H Porteus, Andrew M ScharenbergPageof 20